Weight-based dosing misses accounting for factors such as chronic kidney disease or chronic transaminitis, which could ...

Early use of hydroxychloroquine in adults with isolated discoid lupus is linked to lower 5-year rates of hyperlipidemia, coronary artery disease, and stroke, a study shows.

A new study found a connection between lower doses of hydroxychloroquine (HCQ) and increased risk of hospitalization in people with active systemic lupus erythematosus (SLE). HCQ (known commercially ...

The Lupus Foundation of America has been working to address the shortage of hydroxychloroquine for people with lupus. In addition to providing tips for refilling hydroxychloroquine prescriptions and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Update of ACR guidelines for systemic lupus ...

Hydroxychloroquine use in patients with lupus nephritis was significantly associated with greater improvement in eGFR slope over the first 5 years than over 10 years. Hydroxychloroquine (HCQ) use in ...

In this retrospective analysis, responses persisted with hydroxychloroquine treatment. Results of a study suggest treatment using hydroxychloroquine (HCQ) for immune thrombocytopenia (ITP) related to ...

Please provide your email address to receive an email when new articles are posted on . The risk for birth defect were not statistically significantly higher in pregnancies with lupus or RA exposed to ...

Hydroxychloroquine does not increase the risk of arrhythmia, a large study in Arthritis & Rheumatology has found. The study was precipitated by controversy surrounding hydroxychloroquine and a ...

Eventual tapering and withdrawal of steroids in patients with lupus nephritis is recommended to minimize the drugs' adverse effects, but the ideal timing is uncertain. This study followed 136 lupus ...